IAS 2007 - Committees
- Conference Organising Committee
- Scientific Committee
- Track committees
Conference Organising Committee
- Pedro Cahn, IAS President and International Conference Chair
- David Cooper, Local Conference Chair
- Julio Montaner, IAS President-Elect
- Sharon Lewin, Deputy Local Conference Chair
- John Kaldor, Deputy Local Conference Chair
- Craig McClure, IAS Executive Director
- Mats Ahnlund, IAS Conference Director
- Narasappa Matthew Samuel, IAS Regional Representative
- Levinia Crooks, ASHM Chief Executive Officer
Scientific Committee
- David Cooper, Australia
- Jennifer Hoy, Australia
- John Kaldor, Australia
- Pontiano Kaleebu, Uganda
- Stephen Kent, Australia
- Thomas Kerr, Canada
- Alan L. Landay, United States of America
- Sharon Lewin, Australia
- Patrick Li Chung-ki, China
- Damian Purcell, Australia
- Gita Ramjee, South Africa
- Robert Schooley, United States of America
- Community representative, TBD
Track Committees
Basic Science
Co-chairs
Pontiano Kaleebu
Assistant Director
Medical Research Council/ Uganda Virus Research Institute Unit on AIDS
Pontiano Kaleebu, is Assistant Director at the Uganda Virus Research Institute (UVRI) and Head of the Basic Sciences Programme of the Medical Research Council/UVRI Uganda Research Unit on AIDS. He also leads the UVRI/IAVI HIV Vaccine Trials Unit in Entebbe, Uganda. He is the Chairman of the WHO-UNAIDS African AIDS Vaccine Programme (AAVP) Steering Committee, a member of the WHO-UNAIDS AIDS Vaccine Advisory Committee, a coordinating committee member of the Global HIV Vaccine Enterprise, a board member of the South African AIDS Vaccine Initiative (SAAVI), a board member of the AIDS Vaccine Advocacy Coalition (AVAC) based in New York, and an honorary lecturer at London School of Hygiene and Tropical Medicine.
Alan L. Landay
Professor and Chairman
Dept Immunology/Microbiology
Rush University Medical Center, Chicago
Dr Alan Landay is Professor and Chairman of the Department of Immunology/Microbiology at Rush University Medical Center in Chicago. Dr Landay served as Chair of the National Committee of Clinical Laboratory Standards Committee on Flow Cytometry which produced the first national standard on CD4 testing. Dr Landay’s current research focus is on immune pathogenesis and immune based therapy of HIV disease and he is past Chair of the Immunology Research Agenda Committee of the AIDS Clinical Trial Group NIH Program. Dr Landay is Chair of the Office of AIDS Research Panel on Pathogenesis.
Damian Purcell
Senior Lecturer and Head of Molecular Virology
University of Melbourne, Dept Microbiology and Immunology
Dr Damian Purcell is Senior Lecturer in Virology and Head of the Molecular Virology Laboratory at the Department of Microbiology and Immunology at the University of Melbourne. He commenced HIV molecular virology studies in 1991 at the Laboratory of Molecular Microbiology at the National Institute of Allergy and Infectious Diseases at the NIH, then returned to the Macfarlane Burnet Institute in Melbourne where he established an HIV-1 RNA processing laboratory. In 2001, he accepted a tenured faculty position in the Department of Microbiology and Immunology at the University of Melbourne. He was founding co-head of the HIV-Virology Interest Group (HIV-VIG) of the Australian Center for HIV and Hepatitis Virology (ACh3) and in 2004 he was co-convener for the inaugural ACh3 annual scientific meeting. He is a member of the Australian HIV vaccine consortium, and vaccine design and development committee.
Members
Cecelia Cheng-Mayer
Professor
Aaron Diamond AIDS Research Center
Cecilia Cheng-Mayer is Staff Investigator and Professor at the Aaron Diamond AIDS Research Center in New York. She is a member of the American Society for Microbiology and the American Association for the Advancement of Science. Professor Cheng-Mayer is also Associate Editor of Virology and sits on the editorial boards of AIDS Research & Human Retroviruses and Journal of Acquired Immune Deficiency Syndromes.
Suzanne Crowe
Professor of Medicine, Monash University
Head, AIDS Pathogenesis Research Unit
Consultant Physician in Infectious Diseases and General Medicine, Alfred Hospital
Head, HIV Pathogenesis and Clinical Research Program, The Burnet Institute
Professor Crowe is Head of the AIDS Pathogenesis Research Program and Head of the HIV Clinical Research Laboratory at Burnet Institute, Melbourne. Her clinical appointment is Principal Specialist in Infectious Diseases at the Alfred Hospital, Melbourne. She is Professor of Medicine and Infectious Diseases at Monash University, Melbourne. She is/has served on the Editorial Boards of AIDS, Journal of Infectious Diseases, Sexual Health and Current HIV Research. She is an adviser and consultant to the World Health Organisation Global Program on AIDS, and was President of the Australasian Society for HIV Medicine.
Anthony Cunningham
Professor and Director, Westmead Millennium Institute
Director, Australian Centre for HIV and Hepatitis Virology Research (ACh3)
Professor Cunningham is director of the Westmead Millennium Institute at Westmead Hospital and Professor of Research Medicine and Sub-Dean (research) for the Western Clinical School of the University of Sydney and also Network Director Research for the Sydney West Area Health Service. He was appointed Associate Professor of Virology / Medicine in the University of Sydney, Department of Medicine in 1989. In 2001 he was appointed Deputy Director and in 2002 Director of the Australian Centre for HIV and Hepatitis Virology Research (ACh3) (formerly National Centre for HIV Virology Research). His research interests focus on viral medicine, especially basic biology pathogenesis, seroepidemiology, diagnosis and anti-viral treatment of HIV and herpes virus infections. He has particular clinical research interests in the epidemiology of HSV2 and the development of new antivirals and vaccines for genital herpes.
Daniel Douek
Chief, Human Immunology Section
Vaccine Research Center, NIAID
National Institutes of Health, USA
Daniel Douek is Chief of the Human Immunology Section at the Vaccine Research Center at the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Maryland. He is also Adjunct Professor in the Department of Pathology of the University of Pennsylvania. He is currently on the NIH Plan for HIV-Related Research, Etiology and Pathogenesis Planning Committee and the International Steering Committee of the Israel Vaccine Research Initiative. Professor Douek is on the advisory councils for The American Foundation for AIDS Research and The Elizabeth Glaser Pediatric AIDS Foundation, and on the editorial boards of The Journal of Pathology and The Journal of Clinical and Experimental Immunology.
Genoveffa Franchini
Chief, Animal Models and Retroviral Vaccines Section
National Cancer Institute
Genoveffa Franchini is Chief, Animal Models & Retroviral Vaccines Section, Vaccine Branch, National Cancer Institute, USA. She is a member of the Italian Society of Haematology; the Italian Society of Medicine; the American Society of Clinical Investigation, and is a committee member of the International Retrovirology Association. She is on the editorial boards of AIDS Research and Human Retroviruses, AIDS Reviews, AIDS Treatment Strategies, Journal of AIDS, Journal of Virology; and Virology and AIDS Abstracts. Dr Franchini’s major research interests are to investigate how HTLV-1 proteins subvert cellular and physiological pathways of T cells and lead to their transformation, and to develop strategies for preventive vaccines and therapeutic vaccines for HIV-1.
Ashley Haase
Regents’ Professor and Head, Dept Microbiology
University of Minnesota Medical School
Ashley Haase is currently a Regents’ Professor and Head of the Department of Microbiology at the University of Minnesota. Dr Haase and his colleagues have been trying to understand how lentiviruses elude host defences, sidestep current therapies, and cause disease with the objective of designing better ways to prevent and treat these slow infections. Dr. Haase’s work in the lentivirus visna was awarded the prestigious Senator Jacob Javits Award in Neurosciences from the National Institute of Neurological Disorders and Stroke. He is a member National Academy of Sciences’ Institute of Medicine and the American Academy of Microbiology.
Kuan-Teh Jeang
Chief, Molecular Virology Section
Laboratory of Molecular Microbiology
National Institute of Allergy and Infectious Diseases
National Institutes of Health, USA
Dr. Jeang has been at the National Institutes of Health since 1985. He is Chief of the Molecular Virology Section in the Laboratory of Molecular Microbiology at the National Institute of Allergy and Infectious Diseases. He has published more than 200 peer reviewed articles and book chapters, and is a founding editor for the journals, Journal of Biomedical Science and Retrovirology. He is an associate editor for Cancer Research and serves on the editorial boards of Journal of Virology and the Journal of Biological Chemistry. His research interests have focused on the gene regulation of the human immunodeficiency virus (HIV-1) and the human T-cell leukemia virus (HTLV-I); and how these two viruses cause human diseases.
Esper Kallas
Affiliated Professor of Medicine
Director, Laboratory of Immunology II, Infectious Diseases Division
Federal University of Sao Paulo, Brazil
Esper Kallas is an Infectious Diseases Specialist and Affiliated Professor of Medicine at the Federal University of São Paulo. After training in infectious diseases and vaccine immunology at the University of Rochester, NY, he has been working in the study of HIV pathogenesis, co-infections, and HIV vaccines. Dr. Kallas leads a Clinical Unit in São Paulo, Brazil, which is working in several projects including Phase I and II vaccine trials.
Anthony Kelleher
Head, Immunovirology and Pathogenesis Program,
National Centre in HIV Epidemiology and Clinical Research, UNSW
Dr Kelleher is Program Head of the Immunovirology and Pathogenesis Program of the NCHECR. He has been the Principal Investigator for a number of therapeutic and prophylactic vaccine trials. He has an extensive track record in defining T cell responses in HIV infection. His laboratory currently monitors T cell immune responses in natural history studies and trials of prophylactic and therapeutic vaccines as well as immunotherapeutics for HIV.
Lynn Morris
Associate Professor, University of the Witwatersrand
Head, AIDS Virus Research Unit
National Institute for Communicable Diseases, South Africa
Lynn Morris is the Chief Specialist Scientist at the National Institute for Virology in Johannesburg. In addition, she is head of the AIDS Unit at the Institute, and is a lecturer at the Department of Virology at the University of Witwatersrand. In 2005, she was Chairperson of the 2nd South African AIDS Conference, and in 2006 became an editorial board member of Current HIV Research. Dr Morris has also published more than 40 HIV related papers since 2001.
Guido Poli
Associate Professor of Pathology
Vita-Salute San Raffaele University School of Medicine
Head, AIDS Immunopathogenesis Unit, San Raffaele Scientific Institute
Guido Poli is Associate Professor of Pathology and Immunology at the Vita-Salute San Raffaele University in Milan. He is also the Head of the AIDS Immunopathogenesis Unit, San Raffaele Scientific Institute in Milan. He is Associate Editor of AIDS and is on the editorial boards of Medicinal Chemistry and Drug Design Reviews.
Kiat Ruxrungtham
Associate Professor of Medicine
Head, Division of Allergy and Clinical Immunology, Department of Medicine Chulalongkorn University, Thailand
Kiat Ruxrangtham is Associate Professor of Medicine, Chulalongkorn University; Head of the Division of Allergy and Clinical Immunology, Department of Medicine, Faculty of Medicine, at Chulalongkorn University; and Deputy Director of HIV-NAT (The HIV Netherlands, Australia, Thailand Research Collaboration, AIDS Research Center), Thai Red Cross Society. Professor Ruxrungtham is also a member of The Royal College of Physicians, Thailand, secretary of the Thai AIDS Society, and the Research and Academic Co-ordinator of the Allergy and Immunology Society of Thailand.
Olivier Schwartz
Virus and Immunity Group, CNRS (French National Centre for Scientific Research)
Institut Pasteur
Olivier Schwartz has been Director of the Virus and Immunity Group at the Institut Pasteur since 2002. His main research contributions have been in the understanding of the virological and immunological interactions between HIV and its target cells.
Alexandra Trkola
Assistant Professor, Division of Infectious Diseases
University Hospital Zürich
Alexandra Trkola is Assistant Professor at the Division of Infectious Diseases and Hospital Epidemiology at the University Hospital in Zurich. She has worked as a research scientist at the Aaron Diamond AIDS Research Centre in New York, as Assistant Professor at Rockefeller University in New York, and as Staff Investigator in the Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich.
Carolyn Williamson
Associate Professor, Institute for Infectious Diseases and Molecular Medicine
University of Cape Town
Head, HIV Diversity and Pathogenesis Laboratory and
HIV Molecular Biology and Sequencing Core Laboratory
Carolyn Williamson is Associate Professor at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town. She is currently a member of the Scientific Advisory Board (SAB) of International AIDS Vaccine Initiative (IAVI), a member of the Executive Committee for Centre for AIDS Research in South Africa (CAPRISA), and is on the editorial board of both Current HIV Research and The Journal of Virology. Professor Williamson is currently involved in five ongoing basic science HIV research projects.
Clinical Research, Treatment and Care
Co-chairs
Jennifer Hoy
Associate Professor, Dept Medicine, Monash University
Head, Clinical Research Unit
Infectious Diseases, Alfred Hospital, Melbourne
Associate Professor Hoy is Head of the Clinical Research Unit of the Infectious Diseases Department of the Alfred Hospital in Melbourne. She has served as member and chair of several working groups of the National Centre for HIV Epidemiology and Clinical Research since 1991, and is currently chair of the Toxicology and Pharmacology Working Group, as well as the Protocol Working Group. She has served on the National Executive of the Australasian Society in HIV Medicine for 10 years, including two years as President of the Society in 2000-2001. She was co-editor of the 4th ASHM Monograph on the Management of HIV in Australasia, and took a leading role in the development of the Australian Antiretroviral Guidelines.
Patrick Chung-Ki Li
Chief of Service, Dept Medicine
Queen Elizabeth Hospital, Hong Kong
Dr Patrick Chung-Ki Li is Chief of Service at the Department of Medicine, Queen Elizabeth Hospital, Hong Kong. Hi is currently Co-Chairman for the AmFAR TREAT Asia program and Vice Chairman of the Hong Kong AIDS Foundation. Dr Chung-Ki Li has also served as past President of the Hong Kong Society for Infectious Diseases and as past Chairman of the Global Chinese AIDS Network.
Robert Schooley
Professor of Medicine and Head, Division of Infectious Diseases
University of California, San Diego
Dr. Schooley is Professor and Head of the Division of Infectious Diseases at the University of California, San Diego. He received his M.D. degree from the Johns Hopkins University and received postdoctoral training at Johns Hopkins, the NIH and the Massachusetts General Hospital before serving on the faculties of the Harvard Medical School and the Universities of Colorado and California. He served as Chair of the NIAID’s AIDS Clinical Trials Group from 1995 – 2002. He has research interests in the pathogenesis and therapy of HIV and hepatitis C virus.
Members
Bruce Brew
Head, Dept Neurosciences and Neurology, St Vincent’s Hospital
Professor of Medicine (Neurology), University of New South Wales
Professor Brew is head of Neurology at St Vincent’s Hospital Sydney, consultant to the National Centre in HIV Epidemiology and Clinical Research, and Professor of Medicine (Neurology) at the University of New South Wales. He is a member and founding chairperson of the Neurology working group of the National Centre in HIV Epidemiology and Clinical Research, Sydney. His interests include all aspects of HIV involvement of the nervous system, especially AIDS dementia. He has held numerous grants from national and international bodies including National Institutes of Health (USA). Publications include three books, 76 book chapters/reviews and 127 peer reviewed journal articles.
Elizabeth Connick
Associate Professor of Medicine
Division of Infectious Diseases
University of Colorado at Denver and Health Sciences Center
Dr Connick is Associate Professor of Medicine with an appointment in the Division of Infectious Diseases at the University of Colorado at Denver and Health Sciences Center. She is an immunologist with a specific interest in the immunopathogenesis of HIV-1 infection within lymphoid tissues. She has been involved in clinical trials, including the University of Colorado AIDS Clinical Trials Unit, as well as laboratory-based translational research studies of HIV-1 infection, for the past 12 years. She is well known for studies of immune reconstitution in HIV-infected individuals including immune reconstitution inflammatory syndromes and clinical trials of immune based therapies. She has a longstanding interest in both clinical and immunopathogenesis studies of acute and early HIV infection and is the Principal Investigator of the "Pathogenesis of Acute HIV Infection" program project grant at UCDHSC. Dr Connick is Associate Program Director of the University of Colorado GCRC Boulder satellite and Director of the Colorado CFAR Immunology Core, which provides flow cytometry and microscopy support to investigators at the University of Colorado.
Judith Currier
Associate Director of UCLA CARE (Clinical AIDS Research and Education) Center
Professor of Medicine, UCLA
Dr Currier is currently the Associate Director of the Center for AIDS Research and Education Center (CARE) at the University of California Los Angeles (UCLA), Associate Chief of the Division of Infectious Diseases at UCLA, and Professor of Medicine at UCLA School of Medicine. After three years as the Clinical Director for AIDS at Boston’s Beth Israel, Dr Currier moved to the University of Southern California where she became the Medical Director for the Rand Schrader (5P21) HIV Clinic, one of the largest public HIV clinics in the United States. Dr Currier moved to the University of California, Los Angeles in 1998 to assume the role of Director of the HIV Clinical Trials Unit in the CARE Center. She is currently a member of the Executive Committee of the NIH sponsored AIDS Clinical Trials Group and has served on guideline panels for the management of HIV complications and HIV therapy. Dr Currier was involved in the conduct of clinical trials investigating new antiretroviral therapies for HIV infection. In addition she maintained an active role in studying the complications of HIV infection including metabolic complications of HIV therapy and evaluating sex differences in responses and outcomes of antiretroviral therapy.
Greg Dore
Associate Professor and Head, Viral Hepatitis Clinical Research Program
National Centre in HIV Epidemiology and Clinical Research, UNSW
Infectious Diseases Physician, St Vincent's Hospital
Professor Dore is Head of the Viral Hepatitis Clinical Research Program at the National Centre in HIV Epidemiology and Clinical Research (UNSW), Sydney, and Infectious Diseases Physician at St Vincent’s Hospital, Sydney. Professor Dore has been involved in the areas of HIV and viral hepatitis for many years in academic research, clinical, and public health policy capacities. His major research interests are natural history of acute and chronic HCV infection, HIV/viral hepatitis co-infection, and development of HCV therapeutic strategies, particularly for current injecting drug users. He is chief investigator on several clinical trials, including leading the NIH-funded Australian Trial in Acute Hepatitis C (ATAHC) and Tenofovir in HIV/HBV Coinfection (TICO) studies. Professor Dore has been involved in a broad range of public health activities, including consultancies for the World Health Organization, membership of State and National Hepatitis advisory committees, and Conference Convener for the Australasian Conference on Hepatitis C. His major clinical responsibilities are in the area of viral hepatitis, including co-infection with HIV.
Julian Elliott
Technical advisor, NCHADS, Cambodia
The Burnet Institute, Melbourne
Dr Julian Elliott is currently a lecturer at the National Centre in HIV Epidemiology and Clinical Research (NCHECR) at the University of New South Wales, Sydney, Australia. He has recently moved to the Burnet Institute, Melbourne, following four years as technical advisor in HIV treatment, care and research to the National Center in HIV/AIDS, Dermatology and STDs (NCHADS) of the Cambodian Ministry of Health. In that position he joined efforts to rapidly expand HIV care in Cambodia and to establish an HIV research program. Dr Elliott trained as an infectious diseases physician and has worked in health care programs in central Australian Aboriginal communities, Vietnam and Liberia. He has been a member of the Cambodian National Continuum of Care Committee and various sub-committees and working groups, Australian indigenous health working groups, and international program committees of Oxfam Australia.
Martyn French
Professor, University of Western Australia
Head, Communicable Disease Service, Royal Perth Hospital
Professor French is Head of the Clinical Service of the Department of Clinical Immunology at Royal Perth Hospital and Clinical Professor of Immunology at the University of Western Australia. He has an interest in the clinical immunology of HIV disease and has been involved in the clinical management of HIV patients for 20 years. During this time, he has contributed to many clinical trials and is currently a member of the Antiretroviral Working Group of the Australian National Centre in HIV Epidemiology and Clinical Research and a member of the International Network for Strategic Initiatives in Global HIV Trials (INSIGHT).
José Gatell
Head, Infectious Diseases and AIDS Units and Professor
University of Barcelona
Dr. José M. Gatell is currently Senior Consultant & Head of Infectious Diseases & AIDS Units at the Hospital Clinic of Barcelona and Professor of Medicine at the University of Barcelona. His main research lines in the field of AIDS are clinical investigation of new antivirals, response to the treatment of patients in early stages of HIV-1 disease and immunoreconstitution. He has also done research in endocarditis, tuberculosis and other opportunistic infections associated with parenteral drug addiction and AIDS. He has coordinated several international studies on antivirals and on tuberculosis and served as a member of the Steering Committee of an European Union Program addressed to analyze the characteristics of AIDS in Europe (EUROSIDA). Dr Gatell has been (1997-99) President of the Spanish Society for Infectious Diseases and Clinical Microbiology (SEIMC), is the current president of the European AIDS Clinical Society (EACS) and is Associate Editor of several Spanish and international journals including Clinical Infectious Diseases, Antiviral Therapy, HIV Medicine, HIV Clinical Trials, J AIDS and Medicina Clinica.
Beatriz Grinzstejn
Director
Evandro Chagas Research Institute; Oswaldo Cruz Foundation
Beatriz Grinzstejn is Head of the HIV/AIDS Clinical Research Unit and Head of the Infectious Disease Service at the Evandro Chagas Clinical Research Institute, Oswaldo Cruz Foundation. She is Principal Investigator of IPEC/FIOCRUZ Site – Adults Clinical Trials Group (ACTG), is on the Brazilian National STD/AIDS Program Research Advisory Committee, the Brazilian Ministry of Health Antiretroviral Therapy Advisory Committee, and is a consultant to the Brazilian National STD/AIDS Program. Dr Grinzstejn also sits on the Editorial Advisory Board of the Brazilian Journal of AIDS.
James Hakim
Associate Professor and Chairman, Dept Medicine
University of Zimbabwe
Dr Hakim is Chair of the University of Zimbabwe’s College of Health Sciences. He is an internist and a clinical epidemiologist with broad clinical, research and administrative experience in diverse settings. He is a fellow of the London and Edinburgh Colleges of Physicians. Dr Hakim has extensive clinical exposure in diverse settings including Uganda, Kenya, United Kingdom, Saudi Arabia, Germany, Zimbabwe and Botswana. He is the site Principal Investigator of a number of DAIDS sponsored therapeutic and preventive studies. He is a member of several international organizations which address research capacity in resource-limited settings for example the International Clinical Epidemiology Network (INCLEN), the Netherlands NACCAP and the USA Forum for Collaborative HIV Research. He has conducted several studies including clinical trials in resource limited settings addressing a broad range of issues in HIV and noncommunicable diseases. His work includes studies on TB pericarditis, cryptococcal and tuberculous meningitis and HIV-related cardiomyopathy. Dr Hakim has gained an intimate understanding of participant and logistical issues that are peculiar to research in resource limited settings.
Adeeba Kumarulzaman
Head, Infectious Diseases Unit
University of Malaya Medical Center
Professor Kamarulzaman established the Infectious Diseases Unit at the University of Malaya Medical Centre, Malaysia. As Head of the Infectious Diseases Unit, she has directed and managed the development of infectious diseases including HIV/AIDS in both its clinical and research components. She is currently the President of the Malaysian AIDS Council, is a member of the Board of Trustee of APCASO (Asia Pacific Council of AIDS Service Organisations), Chairperson of the Steering Committee of TREAT Asia (Therapeutics Research, Education, and AIDS Training in Asia) and co-chair of the Global Policy Initiatives of amfAR. More recently as convenor of the Harm Reduction Working Group of the Malaysian AIDS Council, she spearheaded the advocacy for harm reduction measures which has led to the introduction of methadone maintenance treatment and needle and syringe exchange programmes in Malaysia. She serves on the United Nations Regional Task Force for HIV Prevention amongst Drug Users and is on the Executive Committee Board of the International Harm Reduction Association.
Nagalingeswaran Kumarasamy
Chief Medical Officer
YRG Centre for AIDS Research and Education (YRG Care), India
Dr Kumarasamy is the Chief Medical Officer at YRG CARE Chennai, an organisation involved in providing medical care for more than 9000 persons with HIV in Southern India. He is Principal Investigator for the ACTG and HPTN studies of National Institutes of Health/USA for the Chennai site, and Clinical Investigator for several ongoing clinical research projects of YRG CARE and Brown University/USA collaboration. Dr Kumarasamy is a steering committee member of TAHOD-TREAT Asia, a Governing Council member of the International Infectious Diseases Society, and an expert panel member on the WHO- ARV Treatment Guidelines Committee. His research interests include natural history of HIV disease in India, and the use of antiretroviral drugs in resource limited settings. He has also published more than 90 manuscripts in medical journals, presented more than 100 papers in conferences and contributed to 8 book chapters.
Daniel Kuritzkes
Director of AIDS Research, Brigham and Women's Hospital
Associate Professor of Medicine, Harvard Medical School
Daniel Kuritzkes is Associate Professor of Medicine and Director of AIDS Research, Brigham & Women’s Hospital, Harvard Medical School. He is also Head of the Section of Retroviral Therapeutics for the Harvard Division of AIDS, and Principal Investigator of the Harvard AIDS Clinical Trials Unit. Dr Kuritzkes has written widely on antiretroviral therapy and on the problem of drug resistance in HIV-1 infection. He has chaired several multicentre studies of HIV therapy and is a member of the International AIDS Society-USA panel on HIV drug resistance and resistance testing. He has served on numerous NIH committees and editorial boards, and currently chairs the AIDS Clinical Trials Group Scientific Agenda Steering Committee, in addition to serving as Vice Chair of the ACTG Executive Committee. Dr Kuritzkes is Associate Editor of the Journal of Infectious Diseases and Chair, Board of Directors of the HIV Medicine Association. His research interests focus on antiretroviral therapy and drug resistance.
James McIntyre
Executive Director, Perinatal HIV Research Unit
Associate Professor, Dept Obstetrics and Gynaecology
University of the Witwatersrand
Professor McIntyre is Executive Director of the Perinatal HIV Research Unit of the University of the Witwatersrand, South Africa, based at the Chris Hani Baragwanath Hospital in Soweto, one of Africa’s largest AIDS research centres working in HIV prevention, treatment and care, and HIV vaccines. He was also the co-founder and co-director from 1994 to 2002 of the Reproductive Health Research Unit, and was the founding chairman of the University of the Witwatersrand’s AIDS Research Institute. Professor McIntyre leads the CIPRA-SA Safeguard the household collaborative South African research program, funded by the US National Institutes for Health. He is an international authority on mother-to-child transmission of HIV and HIV in women, and has served as a consultant to the WHO, UNAIDS and UNICEF. He was jointly awarded the 2002 Nelson Mandela Award for Health And Human Rights, and the 2003 Heroes in Medicine award of the International Association of Physicians in AIDS Care (IAPAC).
Ronald Mitsuyasu
Professor of Medicine
Director, UCLA Center for Clinical AIDS Research and Education (CARE)
David Geffen School of Medicine, UCLA
Dr Mitsuyasu is Professor of Medicine and the Director of the Center for Clinical AIDS Research and Education (CARE Center) at the Geffen School of Medicine at the University of California, Los Angeles. Dr Mitsuyasu is the Associate Director of the UCLA AIDS Institute responsible for overseeing the clinical therapeutic and biomedical prevention areas. He established one of the first clinics for Kaposi’s sarcoma and AIDS malignancies at UCLA in 1983 and has directed the CARE Center since its inception in 1990. He is the current group chair of the NCI-funded AIDS Malignancy Consortium (AMC) and is director of the State of California-supported Collaborative Center for HIV/AIDS Research in California, which is known as the Network for AIDS Research in Los Angeles (NARLA). He is a past chair of the Immunology Research Agenda Committee (IRAC) of the NIAID Adult AIDS Clinical Trials Group (AACTG) and has served on the Executive and Scientific Agenda Steering Committees of the AACTG. Dr Mitsuyasu’s research interests include clinical trial investigations of cytokines, immune-based therapies, biologic response modifiers, vaccines and gene therapies for HIV and treatments for AIDS-related malignancies. He has extensive background in the use of cytokines, other biologic interventions, bone marrow and stem cell transplants and other novel therapies for HIV. He has pioneered the use of gene therapy for HIV infection.
William Powderly
Professor of Medicine and Therapeutics
Head, UCD School of Medicine and Medical Science
University College Dublin, Ireland
William G. Powderly is Head of the School of Medicine and Medical Science at University College Dublin. He is Professor of Medicine and Therapeutics at UCD and the Mater University Hospital in Dublin. Until July 2004, he was Professor of Medicine at Washington University School of Medicine in St. Louis, Missouri, USA where he was chief of the Division of Infectious Diseases. Professor Powderly has been actively involved in HIV-related clinical research for the last 18 years and has held many leadership roles in the US Adult AIDS Clinical Trials Group, including Vice-Chair of the Group and chair of its Scientific Steering Committee. He was a member of numerous advisory groups for the National Institutes of Health and the Centers for Disease Control and Prevention in the USA. He was also the first Chairman of the HIV Medicine Association in the USA. His research interests currently concentrate on the emerging toxicities of treatment of HIV, especially the metabolic complications seen in patients receiving effective therapy. He is a Fellow of the Infectious Diseases Society of America, of the Royal College of Physicians of Ireland and of the American Association for the Advancement of Science.
Virat Sirisanthana
Professor of Pediatrics
Head, Infectious Disease Unit,
Department of Pediatrics,
Faculty of Medicine, Chiang Mai University
Virat Sirisanthana is Professor of Pediatrics and Head of Division of Infectious Disease in the Department of Pediatrics, Faculty of Medicine at Chiang Mai University, Thailand. Dr Sirisanthana is currently a member of the Thai Ministry of Public Health Advisory Committee in Pediatric AIDS, and a member of the Pediatric Infectious Diseases Sub-board Committee of The Royal College of Pediatricians of Thailand. Dr Sirisanthana is the author of 29 HIV related publications, and is involved in various research projects investigating ART for children in Thailand.
Biomedical Prevention
Co-chairs
Stephen Kent
Professor, Dept Microbiology and Immunology
Head, HIV Vaccine Research Laboratory
University of Melbourne
Professor Stephen Kent is head of the HIV Vaccine Research Laboratory in the Department of Microbiology and Immunology at the University of Melbourne. He has a broad interest in protection and therapy of HIV by vaccines. His group has studied various live attenuated vaccines, recombinant protein vaccines, virus-like-particle vaccines, DNA vaccines, poxvirus vector vaccines and peptide based vaccines in primate models and some of these approaches have proceeded to human trials. He is also an infectious diseases physician caring for people with HIV infection at the Alfred Hospital and Melbourne Sexual Health Centre, Australia.
Thomas Kerr
Assistant Professor, Dept Medicine
University of British Columbia
Research Scientist, British Columbia Centre for Excellence in HIV/AIDS
Dr Thomas Kerr is a research scientist at the British Columbia Centre for Excellence in HIV/AIDS and an Assistant Professor in the Department of Medicine at the University of British Columbia, Canada. In Vancouver, Dr. Kerr oversees a large program of research focused in the areas of urban health and HIV/AIDS, and he is a co-principal investigator of several prospective cohort studies involving injection drug users and street youth, including the Vancouver Injection Drug Users Study (VIDUS). Through these cohort studies, Dr. Kerr's team has evaluated a number of innovative public health and policy initiatives. Dr. Kerr obtained his PhD in the area of health psychology from the University of Victoria, Canada.
Gita Ramjee
Professor and Director, HIV/AIDS Lead Programme and
HIV Prevention Research Unit
Medical Research Council, South Africa
Professor Ramjee is the Director of the South African Medical Research Council HIV/AIDS Lead Programme and Director of the MRC HIV Prevention Research Unit. Prof Ramjee is involved in numerous international research programmes and clinical trials in the field of HIV prevention. She is the Principle Investigator on 3 Phase III and 1 Phase IIB microbicide trials, 1 Phase III trial of the vaginal diaphragm and a trial to test the effectiveness of short-course ARV therapy at HIV-1 seroconversion. Professor Ramjee and her team of 270 researchers and support staff are involved in the testing of 5 out of 6 microbicide products that have reached this advanced stage of development. Professor Ramjee is a long-standing contributor to the International AIDS Conference, having served as committee member and reviewer of abstracts. She was also the co-chair of the recent Microbicides 2006 Conference which took place in South Africa.
Members
Judith Auerbach
Vice President, Public Policy and Program Development
amfAR, The Foundation for AIDS Research
Dr Auerbach is Vice President of Public Policy and Program Development at amfAR (The Foundation for AIDS Research), where she is responsible for developing, leading, and managing amfAR’s Public Policy Office in Washington, DC and for co-ordinating programme activities across the foundation. Prior to amfAR, Dr Auerbach served as Director of the Behavioral and Social Science Program and HIV Prevention Science Coordinator in the Office of AIDS Research at the National Institutes of Health (NIH). In September 2006, Dr Auerbach will be departing amfAR for the San Francisco AIDS Foundation, where she will serve as Deputy Executive Director for Science and Public Policy. Previously, Dr Auerbach was a Senior Program Officer at the Institute of Medicine of the National Academy of Sciences, where she served as Study Director for the Committee on Substance Abuse and Mental Health Issues in AIDS Research. Dr Auerbach’s current research interests focus on two areas: developing basic and intervention approaches to health promotion and disease prevention, taking into account the interplay of biological, behavioral, and social factors; and the social organization of scientific knowledge. Dr Auerbach received the 2004 Feminist Activist Award from Sociologists for Women in Society in recognition of her work on women and HIV/AIDS.
Myron Cohen
J. Herbert Bate Professor
Medicine, Microbiology and Immunology and Public Health
Chief, Division of Infectious Disease
Director, Center for Infectious Disease
The University of North Carolina at Chapel Hill
Myron Cohen is the J. Herbert Bate Distinguished Professor of Medicine, Microbiology and Immunology and Epidemiology at the University of North Carolina at Chapel Hill. Dr Cohen has served as the Director of the UNC Division of Infectious Disease for the past 17 years, and the UNC Center for Infectious Disease for the past 7 years. He is also Associate Director of the UNC Center for AIDS Research. Dr Cohen serves on the Senior Leadership Group of the new NIH Center for HIV Vaccine Immunology (CHAVI) and as the Chair of NIH HPTN Prevention Committee. He is an Associate Editor of the journal Sexually Transmitted Diseases and co-Editor of the comprehensive textbook Sexually Transmitted Diseases. His work focuses on the transmission and prevention of transmission of HIV, with emphasis on the role played by STD co-infections. Dr Cohen is the author of more than 400 publications and much of his research has been conducted in resource constrained countries, especially in Malawi and in the People’s Republic of China.
Christopher Fairly
Professor of Sexual Health, University of Melbourne
Director, Melbourne Sexual Health Centre
Christopher Fairly is the current Chair of Sexual Health at the University of Melbourne, Australia, the Director of the Melbourne Sexual Health Centre, and editor of Sexual Health Journal. He has published extensively in refereed journals, and is involved in ongoing sexual health research.
Paul Gorry
Senior Lecturer, Dept Medicine, Monash University
NHMRC R. Douglas Wright Research Fellow
Head, HIV Molecular Pathogenesis Laboratory
Macfarlane Burnet Institute for Medical Research and Public Health
Paul Gorry is Laboratory Head and Senior Research Fellow at the HIV Molecular Pathogenesis Laboratory, Macfarlane Burnet Institute for Medical Research and Public Health in Australia. He is also Senior Lecturer for the Department of Medicine at Monash University in Melbourne, Australia, and Lecturer at the Department of Microbiology & Immunology, University of Melbourne, Australia. Dr Gorry is professionally affiliated with the International Society for Neurovirology, the Australian Society for Medical Research, and the Australian Centre for HIV & Hepatitis Virology Research (ACh3). He has presented at numerous international HIV scientific conferences, and is a member of the Editorial Advisory Board for Current HIV Research.
Andrew Grulich
Associate Professor and Head, HIV Epidemiology and Prevention Program
National Centre in HIV Epidemiology and Clinical Research, UNSW
Associate Professor Grulich is Head of the HIV Epidemiology and Prevention Program at the National Centre in HIV Epidemiology and Clinical Research at the University of New South Wales. He sits on the Federal Government's HIV and Sexually Transmissible Infections Committee, and is a past president of the Australasian Society for HIV Medicine.
Margaret (Peggy) Johnston
Director, Vaccine and Prevention Research Program, Division of AIDS
Assistant Director, HIV Vaccines
National Institute of Allergy and Infectious Diseases, NIH
Dr Johnston currently holds two key positions at the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), USA. As Director of the Vaccine and Prevention Research, Division of AIDS, she has primary responsibility for NIAID’s extramural research programs focused on HIV/AIDS vaccines, topical microbicides and other biomedical prevention approaches. As Assistant Director for HIV Vaccines at NIAID, Dr Johnston serves as a liaison between the extramural and intramural HIV/AIDS vaccine research communities, and with the non-profit and private sectors to help establish productive collaborations and to ensure an integrated and coordinated vaccine and prevention research program. She chairs the Partnership for AIDS Vaccine Evaluation Executive Committee and the MRMC-NIAID HIV Research Coordinating Team, represents NIAID on the Coordinating Committee of the Global HIV/AIDS Vaccine Enterprise, and serves on several international advisory committees.
Smita Joshi
Research Officer, Epidemiology
National AIDS Research Institute, Pune, India
Smita Joshi is a research officer at the National AIDS Research Institute in Pune, India. Dr Joshi previously worked as a resident in the Department of Obstetrics and Gynaecology at Jehangir Hospital and Medical Center, Pune. Dr Joshi has a comprehensive research and publishing profile, and worked as a Clinical Track Committee of the Microbicides 2006 conference at Cape Town, South Africa.
Anatoli Kamali
Epidemiologist and Head, HIV Intervention Program
MRC/UVRI Uganda Research Unit on AIDS
Anatoli Kamali is an epidemiologist at the MRC (UK)/UVRI Uganda Research Unit on AIDS. Dr Kamali is also Head of the Department of Epidemiology & Data Management at the Uganda Virus Research Institute, and Honorary Lecturer at the Department of Infectious Diseases & Tropical Diseases, London School of Hygiene and Tropical Medicine. Dr Kamali is a member of the National Institute of Allergy and Infectious Diseases, Division of AIDS (NIAID) Vaccine and Prevention Data and Safety Monitoring Board (DSMB) for the NIH funded trials in Uganda, and a member of the National Institute of Allergy and Infectious Diseases Division of AIDS (NIAID) International Data and Safety Monitoring Board Africa.
Sophie Le Coeur
Institut National d'Etudes Démographiques (INED)/
Perinatal HIV Prevention Trial (PHPT)
Dr Le Cœur is a research scientist at the Institut National d’Etudes Démographiques (INED), France and is also affiliated with the Department of Immunology and Infectious Diseases at the Harvard School of Public Health, USA. She has been working, since 1985, on mother-to-child transmission of HIV in Africa and in Asia, and is a co-investigator of the Perinatal HIV Prevention Trial (PHPT) group in Thailand. She has also conducted two studies in the Congo to assess the impact of AIDS on mortality and its interaction with maternal mortality. She is currently the principal investigator of a study funded by the Agence Nationale de Recherches sur le Sida (ANRS) on the socio-demographic and economic impact of antiretroviral program in Thailand.
Kenneth Mayer
Professor of Medicine and Community Health
Brown University/Miriam Hospital
Director, Brown University AIDS Program
Medical Research Director, Fenway Community Health, Boston
Kenneth Mayer is Professor of Medicine and Community Health at Brown University School of Medicine, Adjunct Associate Professor of Epidemiology University of Massachusetts, is on the Executive Committee of the Lifespan-Brown-Tufts Center for AIDS Research, and on the Executive Committee of the Brown University AIDS International Training Program Grant. His hospital appointments include Staff Physician and Medical Research Director at the Fenway Community Health Center in Boston, Attending Physician at Beth Israel Hospital, Boston, and Consulting and Attending Staff, Department of Medicine, Miriam Hospital in Providence, Rhode Island. In addition, he is on the editorial board for AIDS Alert, AIDS/HIV Treatment Directory, Opportunistic Infections in HIV Infected Patients, and for AIDS Patient Care and STDs.
Sheena McCormack
Senior Clinical Epidemiologist
MRC Clinical Trials Unit, UK
Sheena McCormack has gained clinical experience as a consultant in three different environments: London teaching hospitals (Chelsea & Westminster, Mortimer Market, St Mary’s), a London clinic located in a community setting (Victoria clinic), and a District General Hospital (Exeter). Dr McCormack’s research interests are in the field of HIV prevention, specifically HIV vaccines and microbicides. She has co-ordinated seven Phase I/II trials including three HIV vaccine trials, one of which she also acted as Clinical Investigator, and two expanded safety trials conducted in Kampala, Uganda, of novel microbicides. She is joint Principal Investigator of the international Microbicides Development Programme (a network of basic scientists investigating Phase I/II trials of novel agents, pre-clinical studies and field trials) and is currently coordinating the first Phase III trial to be conducted in this programme at eight African sites.
Kimberly Page-Shafer
Associate Professor
Dept Medicine, University of California San Francisco
Dr Page-Shafer, Associate Professor in the Department of Medicine at University of California San Francisco, is an epidemiologist at the Center for AIDS Prevention Studies (CAPS), and holds joint appointments in the Department of Epidemiology and Biostatistics and the San Francisco Veterans Administration Center. Her expertise is the epidemiology and prevention of HIV and hepatitis C virus (HCV) infections, with special focus toward intervention research. She has led development of new proposals aimed at evaluating the safety, tolerability and efficacy of chemoprophylactic therapy to prevent HIV-1 acquisition in various high risk groups, working in Cambodia, and Thailand, and as a collaborator in Peru. She leads a large multidisciplinary study of acute and incident HCV infection, investigating immunological correlates of clearance, HCV infectivity, and treatment feasibility and is planning for future HCV vaccine trials in San Francisco. Dr. Page-Shafer is also a faculty member with the UCSF Institute for Global Health and leads research training activities for scientists and physicians internationally including South America, Asia and Africa.
Vinod Kumar Panday
Consultant and Head of Pediatrics
American Academy of Pediatrics and Nchanga South Hospital, Zambia
Vinod Kumar Panday is Consultant Paediatrician and Head of Paediatrics at Nchanga South Hospital, and a Visiting Consultant at Konkola Mine Hospital in Zambia. For the past 15 years he has been involved in the care of children with HIV/AIDS in Zambia, one of the poorest nations of the world. Dr Panday is actively involved in the behavioural research and advocacy of microbicides. He works with local NGOs as an advisor in the care of AIDS orphans and street based children in the local community. He is an International Fellow of the American Academy of Pediatrics, a member of the Section on International Child Health AAP, a member of the International AIDS Society and a member of the International AIDS Economics Network (IAEN).
Mauro Schrechter
Professor of Infectious Diseases
Head, AIDS Research Laboratory
Universidade Federal do Rio de Janeiro, Brazil
Mauro Schrechter is Professor of Infectious Diseases and Head of the AIDS Research Laboratory at Hospital Universitário Clementino Fraga Filho, Universidade Federal de Rio de Janeiro, Brazil. He is a Senior Research Scientist at the National Research Council of Brazil; Associate of the Department of International Health, School of Hygiene and Public Health at Johns Hopkins University; a member of the Consensus Panel on Antiretroviral Therapy for Brazilian Ministry of Health; a member of the Consensus Panel on Antiretroviral Therapy for International AIDS Society; and Epidemiology Section Editor for AIDS Research and Human Retroviruses.
Steve Wesselingh
Professor and Director, The Burnet Institute, Melbourne
Professor Wesselingh is the Director of the Burnet Institute in Melbourne, the largest infectious diseases, immunology and public health institute in Australia. In 1993 he was appointed to the faculty of the Johns Hopkins School of Medicine as Assistant Professor and then returned to Australia in 1994 to set up the Neuro AIDS Research Unit within the Department of Microbiology and Infectious Diseases, Flinders University. He has served on the Board of the Australian Society for Medical Research (ASMR) and as President of ASMR. In 1999 Professor Wesselingh was appointed Professor and Director of the Infectious Diseases Unit at The Alfred Hospital, Monash University School of Medicine, and in 2002 was appointed Director of the Burnet Institute. He is the current chair of the Ministerial Advisory Committee on AIDS, Sexually Transmitted Infection and Blood Borne Viruses and has been intimately involved in the development of Models of Care and Antiretroviral Guidelines for both Australia and Papua New Guinea. His research interests are mainly in the areas of Neuro AIDS, vaccine development and microbicide development.
